4-Methoxy-7-morpholino-2-[(4-hydroxy-4-methylpiperidino)carbonylamino]benzothiazole
Title | Journal |
---|---|
Tozadenant (SYN115) in patients with Parkinson's disease who have motor fluctuations on levodopa: a phase 2b, double-blind, randomised trial. | The Lancet. Neurology 20140801 |
Adenosine A2A receptor as a drug discovery target. | Journal of medicinal chemistry 20140508 |
Quantification of indirect pathway inhibition by the adenosine A2a antagonist SYN115 in Parkinson disease. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20101201 |